Pre-order Enquiry
Request Free Sample
Global Hospital-Acquired Infection Control Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-20420865 | Publishing Date : 08-Mar-2022 | No. of pages : 89
Request Sample
Request Customization
Check Discounts
As the global economy mends, the 2021 growth of Hospital-Acquired Infection Control will have significant change from previous year. According to our researcher latest study, the global Hospital-Acquired Infection Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital-Acquired Infection Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.
The United States Hospital-Acquired Infection Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-Acquired Infection Control market, reaching US$ million by the year 2028. As for the Europe Hospital-Acquired Infection Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-Acquired Infection Control players cover GSK, Merck, Pfizer, and 3M, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection Control market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
The United States Hospital-Acquired Infection Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-Acquired Infection Control market, reaching US$ million by the year 2028. As for the Europe Hospital-Acquired Infection Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-Acquired Infection Control players cover GSK, Merck, Pfizer, and 3M, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection Control market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
